Advertisement

Topics

Abbott Launches Feasibility Trial Of Tricuspid Version Of MitraClip

14:53 EDT 10 Aug 2017 | SCRIP

The TRILUMINATE trial will evaluate safety and effectiveness of its Tricuspid Valve Repair System for treating symptomatic moderate-to-severe tricuspid regurgitation...

      

Related Stories

 

Original Article: Abbott Launches Feasibility Trial Of Tricuspid Version Of MitraClip

NEXT ARTICLE

More From BioPortfolio on "Abbott Launches Feasibility Trial Of Tricuspid Version Of MitraClip"

Quick Search
Advertisement